Zenas BioPharma, Inc., a clinical-stage biopharma company, engages in the development and commercialization of transformative immunology-based therapies. Its lead product candidate is obexelimab, a bifunctional monoclonal antibody designed ...
Leadership
Leon Oliver Moulder Jr., M.B.A.Founder
Founder, CEO & Chairman
Joseph L. Farmer
COO & President
Lisa von Moltke M.D.
Head of Research & Development and Chief Medical Officer
